INCYTE CORPORATION Other Non-Current Liabilities
INCYTE CORPORATION (INCY) had Other Non-Current Liabilities of $126.59 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-04-28
- 2026-03-31: Other Liabilities, Noncurrent $126.59M.
- 2025-12-31: Other Liabilities, Noncurrent $165.27M.
- 2025-09-30: Other Liabilities, Noncurrent $171.18M.
- 2025-06-30: Other Liabilities, Noncurrent $179.91M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-03-31 | $126.59M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $165.27M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $171.18M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $179.91M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $175.59M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $167.54M 10-K · filed 2026-02-10 |
| 2024-09-30 | $144.68M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $142.10M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $151.11M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $149.15M 10-K · filed 2025-02-10 |
| 2023-09-30 | $133.07M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $139.81M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $118.41M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $99.24M 10-K · filed 2024-02-13 |
| 2022-09-30 | $74.68M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $76.06M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $69.47M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $70.41M 10-K · filed 2023-02-07 |
| 2021-09-30 | $62.30M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $57.59M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $54.46M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $58.28M 10-K · filed 2022-02-08 |
| 2020-09-30 | $44.60M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $42.80M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $39.47M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $40.13M 10-K · filed 2021-02-09 |
| 2019-09-30 | $33.89M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $33.76M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $33.67M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $21.93M 10-K · filed 2020-02-13 |
| 2018-09-30 | $21.00M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $20.48M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $21.26M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $19.80M 10-K · filed 2019-02-14 |
| 2017-09-30 | $13.23M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $12.80M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $12.62M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $12.69M 10-K · filed 2018-02-15 |
| 2016-09-30 | $10.08M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $10.12M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $48.23M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $48.38M 10-K · filed 2017-02-14 |
| 2015-09-30 | $50.86M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $51.86M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $52.91M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $54.55M 10-K · filed 2016-02-12 |
| 2014-09-30 | $52.38M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $44.40M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $34.04M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $26.80M 10-K · filed 2015-02-17 |
| 2013-09-30 | $3.39M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $3.43M 10-Q · filed 2013-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |